Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The corneal stromal collagen network is the primary structural framework of the eye's cornea, accounting for approximately 90% of its total thickness and providing the mechanical strength necessary to maintain ocular shape and intraocular pressure (StatPearls: Cornea Anatomy, 2023). It is composed of highly organized Type I and Type V collagen fibrils arranged in parallel lamellae, a configuration that is essential for optical transparency and refractive power (PubMed: PMID 25703474). In pathological conditions such as keratoconus or post-LASIK ectasia, the enzymatic degradation or mechanical weakening of this network leads to progressive corneal thinning and visual distortion (NIH/NEI: Keratoconus, 2022). This network serves as a therapeutic target for corneal collagen cross-linking (CXL), a procedure that utilizes riboflavin as a photosensitizer and UV-A light to create new covalent bonds between collagen fibers (American Academy of Ophthalmology: Corneal Cross-linking, 2023). By increasing the biomechanical stiffness of the stroma, CXL effectively halts the progression of ectatic diseases and prevents the need for corneal transplantation. Additionally, the network is a focus for regenerative medicine approaches aiming to restore corneal clarity after scarring or infection (Nature Communications: PMID 30135450).
Photo-activated induction of covalent cross-links between collagen fibrils to increase biomechanical stability.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal stromal collagen network.